The Concept

Asia-Pacific Vaccine Excellence Awards (AVEA) 2021 is to recognize the Asian vaccine manufacturer and the achievements it has made over the past year. Despite the COVID-19 pandemic, the industry has overcome adversity and continues with its R&D excellence.
'
The purpose of AVEA2021 is to recognize the outstanding achievements of vaccine & supply chain experts, organizations, and the newest technologies in Asia. Featuring top vaccine industry leaders, along with the latest advances in technologies and best practices in R&D and manufacturing, the Asia Pacific Vaccine Excellence Award applauds extraordinary leaders & trendsetters of today and inspires innovators of tomorrow.

AVEA2021 Winners Handbook

Panel of Judges : #AVEA2021

View All Speakers

Frequently Asked Questions

What is the purpose of having the Asia-Pacific Vaccine Excellence Awards?

The Asia-Pacific Vaccine Excellence Awards (AVEA2021) seeks to recognize organizations within the Asia Pacific Region who have engaged in substantial efforts to innovate, optimize processes and uphold a high level of efficacy, quality, and safety in vaccine development and manufacturing. Nominations are free and open to all members of the industry. You don’t have to be a subscriber, an advertiser, a sponsor or a client of IMAPAC’s conferences to be nominated or to win.

What is the Judging Process for the awards?

Two rounds of call for nominations are conducted. Nominations are then passed on to the judging panel. The judging panel is made up of a team of 3 judges who assess the applications online, before making their final decisions on the winners. Finalists will be announced to the industry and a voting process begins. The final category winners will be determined via industry-wide voting over 3 weeks and in the event of a tie, the judging panel intervenes to make the final decision based on the company’s track record over the past years.

en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?

Kindly fill in the form below to receive the handbook via email

    Products of Interest*
    Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

    Subscribe to our mailing list


    Frequently Asked Questions

    1. What is the purpose of having the Asia-Pacific Vaccine Excellence Awards?

    The Asia-Pacific Vaccine Excellence Awards (AVEA) seeks to recognize organizations within the Asia Pacific Region who have engaged in substantial efforts to innovate, optimize processes and uphold a high level of efficacy, quality, and safety in vaccine development and manufacturing. Nominations are free and open to all members of the industry. You don’t have to be a subscriber, an advertiser, a sponsor or a client of IMAPAC’s conferences to be nominated or to win.

    1. What is the Judging Process for the awards?

    Two rounds of call for nominations are conducted. Nominations are then passed on to the judging panel. The judging panel is made up of a team of 3 judges who assess the applications online, before making their final decisions on the winners. Then finalists will be announced to the industry and a voting process begins. The final category winners will be determined via industry-wide voting over 3 weeks and in the event of a tie, the judging panel intervenes to make the final decision based on the company’s track record over the past years.

    1. How many years have the awards been held? 

    Backed by overwhelming industry requests, we will be hosting the 1st ever Asia-Pacific Vaccines Excellence Awards in 2021.

    1. When are the winners announced? 

    Winners will be announced on the 17 - 18 of November and all are invited to attend the award ceremonies

    1. How will the award ceremony look like for main category winners?

    Award ceremonies will be held during the Asia Pacific Vaccine Award Ceremony on 17 - 18 of November 2021 and winners of the main category will be awarded a Virtual Trophy of Excellence and an e-certificate.